Solactive Future Pharmaceutical Europe Index
The Solactive Future Pharmaceutical Europe Index tracks the performance of the 15 largest European pharmaceutical companies by market capitalization, weighted according to their “Innovation Value”, thereby allocating more weight to companies investing a higher percentage of their total assets in research and development.
Master Data
| ISIN: | DE000SLA5EB2 |
| Bloomberg Ticker: | SOLFUPHA Index |
| WKN: | SLA5EB |
Current Quotes
| Last quote (01 Oct 2025): | 734.96 |
| Day range: | 719.58 / 734.96 |
| Change abs./rel.: | 22.42 / 3.15% |
| Year range: | 544.13 / 734.96 |
| Name | Number of shares |
|---|---|
| NOVARTIS AG | 0.322145 |
| ROCHE HOLDING AG | 0.36428 |
| HALEON PLC | 4.208757 |
| RECORDATI SPA | 0.656891 |
| IPSEN SA | 0.594982 |
| GSK PLC | 2.104092 |
| MERCK KGAA | 0.164374 |
| SANOFI SA | 0.451737 |
| SANDOZ GROUP AG | 0.340632 |
| GALDERMA GROUP AG | 0.118127 |
| NOVO NORDISK A/S | 0.738589 |
| ASTRAZENECA PLC | 0.634007 |
| BAYER AG | 0.624132 |
| GENMAB A/S | 0.457756 |
| UCB SA | 0.348672 |